Global Composites Market 2012-2018 & 2022 - Market is Projected to Reach $ 42 Billion
↧
↧
US Metal Service Center Revenue to Reach $165 Billion in 2022
↧
One Man's Journey From Bartender to Striking 'Internet Gold' Is Inspiring Young Entrepreneurs
RICHMOND, Va., June 22, 2018 /PRNewswire/ -- At the age of 24, Myke Metzger finished his 4th weekend in jail for driving on a suspended license, and had just received the news that he had no bartending job to return to.
Without many options left, he ventured out on his own.
Now, a...
↧
Brad Schlachter Joins Civilized As Director Of Audience Acquisition
↧
Strategic Staffing Solutions Names Bob Zhang As Detroit Market Team Leader
↧
↧
InsureMyTrip Upgrades Travel Insurance Recommendation Engine, Adds New Features
↧
ModulTrade Opens Global Market for African SMEs
↧
Johnson Fistel Announces Investigations of Veevo Instruments Inc., Insys Therapeutics, Inc., TAL Education Group and Newell Brands Inc.; Investors Encouraged to Contact Firm
↧
Xcode Life Announces the South Asian Genome (SAGE) Project
↧
↧
Ford Motor Company: Saudi Women Drive
RIYADH, Saudi Arabia, June 23, 2018 /PRNewswire/ --
On June 24, 2018, women in Saudi Arabia will be legally able to drive on the roads of the Kingdom. This is a momentous time in history and we are delighted to be able to welcome Saudi women "to the front", to the driver's seat....
↧
Array BioPharma Announces a 62% Observed Overall Survival at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO 20th World Congress on Gastrointestinal Canc
↧
SPA Selected as a 2018 Washington Post Top Workplace
↧
Cloud With Me: Converting Cloud Adoption Into an Accessible Solution for All
DUBLIN, June 23, 2018 /PRNewswire/ --
What if businesses could eliminate the complexities of internet based services to improve performance? What if it was possible for employees to work from anywhere, at any time, from any device, and still have a single control point on proceedings?...
↧
↧
New Data Show Amgen's Repatha® (evolocumab) Significantly Reduced LDL-C And Non-HDL-C In High-risk Patients With Type 2 Diabetes
↧
Investigational Doses of Lilly's Once-Weekly Trulicity® (dulaglutide) Show Promise in Delivering Powerful Efficacy in People with Type 2 Diabetes
↧
Two-year Data from ViaCyte's STEP ONE Clinical Trial Presented at ADA 2018
↧
Significant blood sugar improvement with Xultophy® 100/3.6 compared to insulin glargine U-100 when used as add-on to oral diabetes medications
↧
↧
Gaumard's Growing Family Takes Center Stage at AWHONN '18
↧
Jardiance® reduced risk of kidney disease progression in adults with type 2 diabetes and established cardiovascular (CV) disease independent of control of conventional CV risk factors
↧
New Data Presented at the American Diabetes Association 78th Scientific Sessions® Reinforce Potential of Lilly's Ultra Rapid Lispro in People with Type 1 and Type 2 Diabetes
↧
More Pages to Explore .....